Related Experiment Video

Updated: Oct 20, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Quality of paediatric IDDM care in Germany: a multicentre analysis. German Paediatric Diabetology Group

W Hecker1, M Grabert, R W Holl

  • 1Olgahospital, Stuttgart, Germany.

Journal of Pediatric Endocrinology & Metabolism : JPEM
|July 7, 1999
PubMed

Insights

Quality management improved care for children with insulin-dependent diabetes mellitus (IDDM). A nationwide survey showed good metabolic control but inconsistent screening for diabetic complications.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Management
  • Quality Improvement in Healthcare

Background:

  • Quality management is increasingly applied to enhance care for pediatric patients with insulin-dependent diabetes mellitus (IDDM).
  • German Paediatric Diabetology Working Group established quality control standards in 1995, defining key parameters for care structure, process, and outcomes.
  • A specialized computer software program was developed for quality control with centralized, anonymous data analysis.

Purpose of the Study:

  • To evaluate the quality of care for children and adolescents with IDDM using a nationwide survey.
  • To assess key performance indicators including hospitalization rates, treatment regimens, metabolic control, and complication screening.

Main Methods:

  • A nationwide survey was conducted using data from 23 pediatric centers, evaluating 2407 patients between January and June 1996.
  • Data analysis involved a computer software program for quality control with central, anonymous analysis.
  • Key metrics assessed included hospital admission rates, duration of stay, insulin therapy types, HbA1c levels, severe hypoglycemia, ketoacidosis incidence, and screening rates for retinopathy and nephropathy.

Main Results:

  • The study reported an annual hospital admission rate of 23.8 per 100 patient-years, with an average inpatient stay of 2.74 days.
  • Eighty percent of patients received intensive insulin therapy (≥3 injections daily), achieving a mean HbA1c of 7.8%, indicating reasonably good metabolic control.
  • Severe hypoglycemia occurred at 6 per 100 patient-years, and ketoacidosis at 1 per 100 patient-years. Screening for diabetic retinopathy and nephropathy was inconsistent, with incidences of 44% and 33%, respectively.

Conclusions:

  • The implemented quality management system provides valuable insights into pediatric IDDM care across Germany.
  • While metabolic control and treatment intensity are generally positive, there is a clear need to improve systematic screening for long-term diabetic complications.
  • Further efforts are required to ensure consistent adherence to screening protocols for retinopathy and nephropathy to prevent long-term morbidity.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...